Literature DB >> 18072137

Seizures in a pediatric patient with a tiagabine overdose.

Ziad N Kazzi1, Chris C Jones, Brent W Morgan.   

Abstract

INTRODUCTION: Tiagabine (TGB) is a novel antiepileptic that decreases GABA uptake. The literature contains one report of an adult with epilepsy who ingested up to 1 gram of TGB and developed status epilepticus. We reported on a pediatric patient who ingested significantly less TGB but still developed tonic-clonic seizures. CASE REPORT: A previously healthy, 13 kg, two-year-old girl developed generalized tonic-clonic seizure activity at home approximately 1 hour after ingesting 90 mg of her grandmother's TGB (forty five 2 mg tablets). At the hospital she had two 5 minute seizures at 1.5 and 3.5 hours post ingestion. Her serum TGB levels were 530 and 130 ng/ml approximately 5 and 11 hours post-ingestion (5-70 ng/ml trough levels with most probable range for seizure control). She was discharged 27 hours post ingestion, and she was in good condition.
CONCLUSION: An overdose of TGB, a novel anti-epileptic, can cause convulsive seizures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18072137      PMCID: PMC3550077          DOI: 10.1007/bf03161185

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  15 in total

1.  Tiagabine overdose can induce convulsive status epilepticus.

Authors:  Denis Ostrovskiy; Marianna V Spanaki; George L Morris
Journal:  Epilepsia       Date:  2002-07       Impact factor: 5.864

2.  Safety of tiagabine: summary of 53 trials.

Authors:  I E Leppik; L Gram; R Deaton; K W Sommerville
Journal:  Epilepsy Res       Date:  1999-02       Impact factor: 3.045

3.  Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients.

Authors:  T Balslev; P Uldall; J Buchholt
Journal:  Eur J Paediatr Neurol       Date:  2000       Impact factor: 3.140

4.  Drug-induced nonconvulsive status epilepticus with low dose of tiagabine.

Authors:  S Fitzek; S Hegemann; D Sauner; D Bönsch; C Fitzek
Journal:  Epileptic Disord       Date:  2001-09       Impact factor: 1.819

Review 5.  Clinical and EEG findings in six patients with altered mental status receiving tiagabine therapy.

Authors:  V de Borchgrave; F Lienard; Th Willemart; K van Rijckevorsel
Journal:  Epilepsy Behav       Date:  2003-06       Impact factor: 2.937

Review 6.  Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature.

Authors:  Christoph Kellinghaus; Rainer Dziewas; Peter Lüdemann
Journal:  Seizure       Date:  2002-06       Impact factor: 3.184

Review 7.  Tiagabine.

Authors:  H Mengel
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

8.  Intentional overdose with tiagabine: an unusual clinical presentation.

Authors:  F Lee Cantrell; Mike Ritter; Ed Himes
Journal:  J Emerg Med       Date:  2004-10       Impact factor: 1.484

Review 9.  GABA transporters and GABA-transaminase as drug targets.

Authors:  Alan Sarup; Orla Miller Larsson; Arne Schousboe
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2003-08

10.  Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.

Authors:  E B Nielsen; P D Suzdak; K E Andersen; L J Knutsen; U Sonnewald; C Braestrup
Journal:  Eur J Pharmacol       Date:  1991-04-24       Impact factor: 4.432

View more
  1 in total

1.  The Influence of Solid Microneedles on the Transdermal Delivery of Selected Antiepileptic Drugs.

Authors:  Julia Nguyen; Kevin B Ita; Matthew J Morra; Inna E Popova
Journal:  Pharmaceutics       Date:  2016-11-15       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.